MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    Auditory rhythmic cueing changes motor control during walking in Parkinson’s disease

    A. Islam, C. Chen, l. Alcock, K. Nazarpour, L. Rochester, A. Pantall (Newcastle-upon-Tyne, United Kingdom)

    Objective: (1) Evaluate changes in gait motor activity patterns induced by auditory rhythmic cueing in people with PD. (2) Investigate change in gait parameters. Background:…
  • 2018 International Congress

    CRISPR/Cas9-based fluorescent tyrosine hydroxylase-reporter lines

    A. Rakovic, F. Vulinovic, C. Klein (Lübeck, Germany)

    Objective: To generate and characterize TH-GFP and -mCherry reporter iPSC lines. Background: Human induced pluripotent stem cells (iPSCs)-based dopaminergic neuronal (iDA) cultures emerged as a…
  • 2018 International Congress

    People with PD have significantly impaired lower limb force production in all muscle groups: A cross sectional study

    E. Preston, R. Salmon, N. Mahendran, A. Flynn (Canberra, Australia)

    Objective: Impaired force production is commonly reported by people with Parkinson’s disease (PD), however, the force production of only a small number of lower limb…
  • 2018 International Congress

    Creating a safe home for Parkinson’s disease patients: Designed principles for modifications

    T. Jantanapornchai, J. Sringean, S. Pensook, P. Sankham, N. Kantachadvanich, S. Phumphid, R. Bhidayasiri (Bangkok, Thailand)

    Objective: To proposed the design principles for home modification in Parkinson's disease based on home visit program. Background: Falling is a significant cause of morbidity…
  • 2018 International Congress

    Speech and Language Therapy (SLT) for Inpatients with Parkinson’s (IwP) in a Large District General Hospital

    J. Martin, A. Chatterjee (Reading, United Kingdom)

    Objective: To improve access to SLT for the MDT and IwP at the Royal Berkshire Hospital. Background: A successful bid in Jan 2017 for a…
  • 2018 International Congress

    Effectiveness and costs of specialised physiotherapy given via ParkinsonNet: A retrospective analysis of medical claims data

    J. Ypinga, N. de Vries, L. Boonen, X. Koolman, M. Munneke, A. Zwinderman, B. Bloem (Tilburg, Netherlands)

    Objective: To study the long-term benefits of specialised physiotherapy using the ParkinsonNet approach in real-world practice. Background: Trials show that specialised allied health interventions are…
  • 2018 International Congress

    Assessing the potential cost-effectiveness of ads-5102 (Amantadine HCl) for the treatment of dyskinesia in Parkinson’s disease patients

    R. Pahwa, L. Garrison, M. Zimmerman, R. Johnson, J. Nguyen, M. Li, R. Patni (Kansas City, KS, USA)

    Objective: This economic evaluation projects the likely cost-effectiveness of ADS-5102 in comparison to the current standard of best supportive care. Background: In August, 2017, the…
  • 2018 International Congress

    Four eyelid and eye movement disorder cases misdiagnosed as seronegative ocular myasthenia gravis

    M. Kamada, K. Kume (Kita-gun, Japan)

    Objective: To report four eyelid and eye movement disorder cases misdiagnosed as seronegative ocular myasthenia gravis. Background: Myasthenia gravis (MG) is a disorder where neurotransmission…
  • 2018 International Congress

    Diagnostic value and capability of DaT (dopamine-transporter) SEPCT scan to assess clinically uncertain Parkinsonism Diseases as a single institutional experience in Kuwait Population

    S. Al Tailji, M. Elgadafi1, W. Kamel, J. Al-Hashel (Kuwait, Kuwait)

    Objective: To evaluate the diagnostic value and capability of DaT scan to increase clinical confidence in order to confirm/rule out the diagnosis, change management and…
  • 2018 International Congress

    Surface Modified Solid Lipid Nanoparticles for the targeted delivery to brain: Management of HIV-1 Associated Dementia

    S. Bhargava, V. Bhargava (Kanpur, India)

    Objective: In this study, nifedipine loaded solid lipid nanoparticles (SLN) were developed for targeting drug into the central nervous system, the site of action of…
  • « Previous Page
  • 1
  • …
  • 1486
  • 1487
  • 1488
  • 1489
  • 1490
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley